Company intelligence / Profile preview

Zhejiang Juvensis Therapeutics Biotechnology

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Juvensis Therapeutics is a clinical-stage biotechnology company based in China, focused on developing innovative gene therapies for heart failure and age-related degenerative diseases. Founded in 2021, the company leverages a proprietary telomere precision modulation technology platform to address the telomere-mitochondria axis of aging. Its lead candidate, JV101, is an AAV9-delivered gene therapy that expresses a modified, catalytically inactive human telomerase reverse transcriptase (hTERT) to recap telomeres, suppress DNA damage responses, and restore mitochondrial biogenesis in cardiomyocytes. Juvensis has received recognition from global pharmaceutical leaders like Novo Nordisk and Boehringer Ingelheim and is advancing a pipeline targeting cardiovascular, neurological, and renal indications.

Therapeutic areas: CardiovascularNephrologyNeurology
Modalities: Gene therapyAAV9Recombinant protein
Industry: Biotech

Partnerships

Novo NordiskBoehringer Ingelheim

Beyond the preview

Go deeper on Zhejiang Juvensis Therapeutics Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Juvensis Therapeutics Biotechnology.

Explore the full profile